Get the Stockscreener App
0.1703
0.53%
-0.0009
After Hours:
.17
-0.0003
-0.18%
Applied Dna Sciences Inc stock is traded at $0.1703, with a volume of 868.07K.
It is down -0.53% in the last 24 hours and down -29.16% over the past month.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
See More
Previous Close:
$0.1712
Open:
$0.1712
24h Volume:
868.07K
Relative Volume:
0.17
Market Cap:
$9.40M
Revenue:
$9.00M
Net Income/Loss:
$-7.21M
P/E Ratio:
-0.3096
EPS:
-0.55
Net Cash Flow:
$-7.59M
1W Performance:
-4.33%
1M Performance:
-29.16%
6M Performance:
-57.43%
1Y Performance:
-98.49%
1-Day Range:
$0.17
$0.173
1-Week Range:
$0.165
$0.1784
52-Week Range:
$0.1204
$14.40
Applied Dna Sciences Inc Stock (APDN) Company Profile
Name
Applied Dna Sciences Inc
Sector
Industry
Phone
631-240-8800
Address
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Compare APDN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
0.1703 | 9.40M | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
572.71 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.01 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
147.64 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
209.96 | 38.11B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
460.56 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-21 | Initiated | ROTH Capital | Buy |
| Jan-14-21 | Reiterated | H.C. Wainwright | Buy |
| Dec-18-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-20-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-02-20 | Initiated | H.C. Wainwright | Buy |
| Nov-14-16 | Reiterated | Maxim Group | Buy |
| May-13-16 | Reiterated | Maxim Group | Buy |
| Oct-08-15 | Reiterated | Maxim Group | Buy |
| May-26-15 | Initiated | The Benchmark Company | Speculative Buy |
| Feb-10-15 | Reiterated | Maxim Group | Buy |
| Jan-13-15 | Initiated | Maxim Group | Buy |
View All
Applied Dna Sciences Inc Stock (APDN) Latest News
A History of Outperforming Analyst Forecasts and Beating the Odds: Applied Dna Sciences Inc (APDN) - SETE News
Breaking down APDN’s current quarter earnings estimates - US Post News
Applied DNA Sciences Announces Change in Certifying Accountant – Form 8-K Filing - Defense World
Applied DNA Sciences Appoints New Auditor By Investing.com - Investing.com South Africa
Applied DNA Sciences Appoints New Auditor - Investing.com
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health - ACCESS Newswire
Applied DNA Sciences, Inc. to Host Earnings Call - ACCESS Newswire
Applied DNA Sciences Holds Special Meeting of Stockholders - Defense World
Applied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit - ACCESS Newswire
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines - ACCESS Newswire
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement - ACCESS Newswire
Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress - ACCESS Newswire
Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates - ACCESS Newswire
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out - ACCESS Newswire
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing - ACCESS Newswire
Applied DNA Sciences fails to secure shareholder vote - MSN
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16 - ACCESS Newswire
Applied DNA Sciences fails to secure shareholder vote By Investing.com - Investing.com Australia
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA - ACCESS Newswire
Applied DNA Launches Mpox Clade I and Clade II Testing Service - ACCESS Newswire
Applied DNA Announces 1-For-20 Reverse Stock Split - ACCESS Newswire
Short Interest in Applied DNA Sciences, Inc. (NASDAQ:APDN) Drops By 5.1% - Defense World
73,396 Shares in Applied DNA Sciences, Inc. (NASDAQ:APDN) Purchased by Jane Street Group LLC - Defense World
Applied DNA Sciences Utilizes Company Presentation for Investor Outreach - Defense World
Applied DNA Sciences Advances in Genetic Medicines Market - TipRanks
APDNApplied DNA Sciences, Inc. Latest Stock News & Market Updates - StockTitan
Applied DNA Sciences Completes GMP Facility for mRNA Production, Eyes $30M Revenue Potential - StockTitan
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter - Weatherford Democrat
Applied DNA Sciences Reschedules Q1 2025 Earnings Call and Strategic Update to February 13 - StockTitan
SABBY MANAGEMENT, LLC Acquires Significant Stake in Applied DNA Sciences Inc - GuruFocus.com
Featured Company NewsApplied DNA Sciences Enters into CertainT Trademark License Agreement with Techmer PM - AccessWire
When Would Be The Best Time To Buy Applied Dna Sciences Inc (NASDAQ: APDN) Stock? - Stocks Register
Applied DNA Sciences Secures Landmark Approval for Revolutionary CAR T-Cell Therapy Trial in Czech Republic - StockTitan
Why US Futures Are Rising WednesdayCorvus Pharma (NASDAQ:CRVS), Applied DNA Sciences (NASDAQ:APDN) - Benzinga
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday - Benzinga
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot - CT Insider
Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Applied DNA Sciences Inc. (APDN) reports earnings - Quartz
Applied DNA Sciences Pivots to Genetic Medicine Manufacturing, Plans Major Restructuring Amid Revenue Drop - StockTitan
Applied DNA Sciences Sets Q4 Earnings Date, to Update on Key Manufacturing Expansion - StockTitan
APDN stock plunges to 52-week low of $0.14 amid steep decline - Investing.com Australia
APDN stock plunges to 52-week low of $0.15 amid market challenges - Investing.com
Applied DNA Sciences, Inc. (NASDAQ:APDN) Sees Large Decrease in Short Interest - Defense World
Analysts Predict How High Applied Dna Sciences Inc (APDN) Will Go. - Stocks Register
Applied DNA stock jumps amid U.S. government mpox update - MSN
Applied Dna Sciences Inc Stock (APDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):